Rosen Law Firm Encourages Tvardi Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – TRVD

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tvardi Therapeutics, Inc. due to allegations of materially misleading business information issued to the investing public [1] Company Summary - Tvardi Therapeutics, Inc. (NASDAQ: TRVD) is facing scrutiny regarding the accuracy of its business communications to investors [1] - Shareholders who purchased Tvardi Therapeutics securities may be entitled to compensation without incurring out-of-pocket fees or costs [1]